Research on the Problems and Countermeasures of Mah in China's Drug Marketing Authorization Holder System

To study the strategies for better implementation of China's drug listing holder system. Method: By comparing the implementation of the MAH system for drug marketing license holders at home and abroad, analyze the problems existing in each link of the system in the pilot implementation of the system in China and propose targeted improvement measures. Conclusion: It is recommended to learn from developed countries' mature experience to make the drug marketing authorization holder system a policy dividend for promoting the scientific and technological progress and long-term development of the pharmaceutical industry.